Similar articles

• [HLA phenotypes in patients surviving a long time after immunotherapy with BCG for acute childhood lymphoblastic leukemia. Arguments in favor of the existance of a gene for immune response in human leukemia].

  Tursz T, Hors J, Lipinski M, Amiel JL. Tursz T, et al. C R Acad Hebd Seances Acad Sci D. 1977 Dec 19;285(16):1585-7. C R Acad Hebd Seances Acad Sci D. 1977. PMID: 417839 French.
• Comparison of HLA phenotypes in long-term survivors with acute lymphoblastic leukemia treated with immunotherapy versus chemotherapy.

  Tursz T, Hors J, Lipinski M, Amiel JL, Mathé G. Tursz T, et al. Recent Results Cancer Res. 1982;80:26-8. doi: 10.1007/978-3-642-81685-7_5. Recent Results Cancer Res. 1982. PMID: 7036290 No abstract available.
• [Data on the immunological profile of children with acute lymphoblastic leukemia treated by immunotherapy].

  Esposito L, Benedetto N, Guerriero A. Esposito L, et al. Pediatria (Napoli). 1980 Dec 31;88(4):521-31. Pediatria (Napoli). 1980. PMID: 6974847 Italian. No abstract available.
• Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants.

  Mastrangelo MJ, Berd D, Bellet RE. Mastrangelo MJ, et al. Ann N Y Acad Sci. 1976;277(00):94-123. doi: 10.1111/j.1749-6632.1976.tb41693.x. Ann N Y Acad Sci. 1976. PMID: 793490 Review. No abstract available.
• Immunological aspects of acute leukemia in man.

  Piessens WF, Moloney WC. Piessens WF, et al. Eur J Cancer (1965). 1976 Jul;12(7):511-7. doi: 10.1016/0014-2964(76)90156-0. Eur J Cancer (1965). 1976. PMID: 782891 Review. No abstract available.